Reaction

Graft Versus Host Disease In Skin reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,173 reports · 103 co-occurring drugs

As of the last recalculation, Graft Versus Host Disease In Skin appears in 2,173 FAERS reports alongside 103 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 292.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Thiotepa	257	292.2	300.3
Busulfan	361	263.3	269.5
Fludarabine Phosphate	676	238.6	242.8
Alemtuzumab	206	112.6	113.8
Sirolimus	118	88.7	89.4
Melphalan	188	86.6	87.3
Melphalan Hydrochloride	203	85.4	86.1
Mycophenolate Mofetil Hydrochloride	725	76.1	76.5
Mycophenolate Mofetil	724	76.1	76.5
Tacrolimus Ointment 0.1%	665	73.3	73.7
Tacrolimus Extended-Release Capsules	665	73.1	73.5
Anti-Thymocyte Globulin (Rabbit)	59	72.0	72.5
Blinatumomab	75	71.3	71.8
Tacrolimus	751	69.7	70.0
Cyclosporine	575	67.0	67.3
Ganciclovir	69	66.7	67.1
Posaconazole Delayed-Release	73	65.8	66.3
Ganciclovir Sodium	70	65.4	65.9
Posaconazole	95	58.5	58.9
Micafungin Sodium	40	46.0	46.2
Mycophenilic Acid	92	44.4	44.6
Basiliximab	52	43.4	43.6
Cyclophosphamide Injection, Solution	543	38.8	39.0
Cyclophosphamide	543	38.8	38.9
Cyclophosphamide For Injection	543	38.8	38.9
Valganciclovir Hydrochloride Powder,	39	31.2	31.3
Mycophenolic Acid	95	29.7	29.8
Ruxolitinib	202	29.7	29.7
Voriconazole Injection	64	29.1	29.1
Azacitidine For	52	28.0	28.1
Valganciclovir	53	27.6	27.7
Valganciclovir Hydrochloride	53	27.6	27.7
Azacitidine	78	26.1	26.1
Methylprednisolone	318	25.6	25.7
Amphotericin B	32	24.8	24.9
Cytarabine	141	24.0	24.0
Voriconazole	73	23.8	23.8
Hydroxyurea	46	21.3	21.3
Atovaquone	16	19.2	19.2
Methylprednisolone Sodium Succinate	85	18.2	18.2
Etoposide	117	16.1	16.1
Ursosiol	32	16.0	16.0
Itraconazole	19	15.7	15.7
Ursodiol	34	15.2	15.2
Meropenem	49	14.9	15.0
Budesonide	88	14.9	14.9
Imatinib	27	14.8	14.9
Filgrastim	56	14.6	14.6
Anakinra	25	14.6	14.6
Sorafenib	30	14.0	14.0
Mesna Injection	12	14.0	14.0
Fluconazole	98	14.0	14.0
Mesna	12	13.7	13.7
Hydrocortisone Sodium Succinate	13	13.3	13.3
Methotrexate	456	12.9	12.9
Prednisolone	212	12.4	12.4
Prednisolone Oral	212	12.4	12.4
Prednisolone Oral Solution	212	12.4	12.4
Acyclovir	137	12.2	12.2
Methotrexate Sodium	488	12.1	12.1
Granisetron Hydrochloride	13	12.0	12.0
Canakinumab	13	11.6	11.6
Methylprednisolone Acetate	9	10.8	10.8
Sulfamethoxazole And Trimethoprim	79	9.3	9.3
Dalteparin Sodium	10	9.1	9.1
Hydroxyzine Hydrochloride	12	8.8	8.8
Hydroxyzine Hydrochloride Oral	12	8.8	8.8
Piperacillin Sodium,Tazobactam Sodium	24	8.8	8.8
Vancomycin Hydrochloride	58	8.6	8.6
Brentuximab Vedotin	9	8.4	8.4
Cefepime Hydrochloride	14	8.4	8.4
Daptomycin	8	8.3	8.3
Magnesium Sulfate Heptahydrate	11	8.1	8.1
Vancomycin	48	8.1	8.1
Magnesium Sulfate	11	8.1	8.1
Dasatinib	31	8.1	8.1
Rituximab	160	7.7	7.8
Magnesium Sulfate In Water For	10	7.5	7.5
Everolimus Tablets	13	7.5	7.5
Oseltamivir	6	7.2	7.2
Levofloxacin	44	7.1	7.1
Levofloxacin In 5% Dextrose	44	7.1	7.1
Daspone	7	6.9	6.9
Dapsone Gel, 5%	7	6.9	6.9
Bendamustine Hcl	11	6.8	6.8
Thalidomide	24	6.3	6.3
Dapsone	7	6.3	6.3
Valacyclovir	27	6.3	6.3
Venetoclax	39	6.2	6.2
Cefepime	9	6.0	6.0
Piperacillin And Tazobactam	8	6.0	6.0
Cladribine	6	6.0	6.0
Nilotinib	18	5.9	5.9
Eltrombopag Olamine	13	5.4	5.4
Norepinephrine	6	5.4	5.4
Ibrutinib	41	4.9	4.9
Levetiracetam In Sodium Chloride	38	4.8	4.8
Levetiracetam Oral	38	4.8	4.8
Levetiracetam Injection	38	4.8	4.8
Granisetron	5	4.6	4.6
Doxorubicin	36	3.9	3.9
Axicabtagene Ciloleucel	4	3.9	3.9
Remdesivir	4	2.9	2.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.